DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
9 hedge funds and large institutions have $44.7M invested in DermTech, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and 8 closing their positions.
108% more capital invested
Capital invested by funds: $21.5M → $44.7M (+$23.2M)
25% less funds holding
Funds holding: 12 → 9 (-3)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.84M |
| 2 |
VF
Virtu Financial
New York
|
+$113K |
| 3 |
CC
Centiva Capital
New York
|
+$107K |
| 4 |
Millennium Management
New York
|
+$93.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$1.39M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$651K |
| 3 |
CAC
Cowen and Company
New York
|
-$515K |
| 4 |
KC
Kepos Capital
New York
|
-$434K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$84K |
DMTK Hedge Fund Activity: Q4 2019 in Review
9 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2019, worth a combined $44.7M — up 108% from $21.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of DMTK and 5 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Vanguard Group, opening a new position worth an estimated $1.84M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $1.39M sold.
- 9 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2019, down from 12 in Q3 2019.
- Funds reported $44.7M of DermTech, Inc. Common Stock stock for Q4 2019, up 108% quarter-over-quarter.
- 5 funds opened new DermTech, Inc. Common Stock positions in Q4 2019 and 8 closed out, a net change of -3 holders.
- The largest DermTech, Inc. Common Stock buyer in Q4 2019 was Vanguard Group, an estimated $1.84M added.
- The largest DermTech, Inc. Common Stock seller in Q4 2019 was D.E. Shaw & Co, an estimated $1.39M sold.
Based on aggregated 13F filings for Q4 2019.